Skip to main content

Adriamycin News

Subsequent Breast Cancer Risk Higher for Child Cancer Survivors Receiving Doxorubicin

TUESDAY, Sept. 19, 2023 – For female survivors of childhood cancer, the risk for subsequent breast cancer (SBC) is more than twofold higher for those who receive a cumulative dose of 200 mg/m² or ...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related condition support groups

Breast Cancer, Acute Lymphoblastic Leukemia, Thyroid Cancer, Ovarian Cancer, Lymphoma, Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Cancer

Adriamycin patient information at Drugs.com